John Thomas

Track

Insider profile

Currently holds a position at Immunitybio Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 20% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Immunitybio Inc April 1, 2014 -
Independent Director Novelion Therapeutics Inc June 4, 2012 - Sept. 24, 2019
John Thomas's trades of Immunitybio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-12-16 2019-12-16
PlS Planned sale
79,260 -17.2%
493.34
US$2,014,560 		79,260 -17.2% 493.34 US$2,014,560
2019-12-16 2019-12-13
PlS Planned sale
7,631 -17.5%
153.34
US$2,349,576 		7,631 -17.5% 153.34 US$2,349,576
2019-12-16 2019-12-13
PlS Planned sale
86,070 -31.0%
101.89
US$4,401,749 		86,070 -31.0% 101.89 US$4,401,749
2019-12-12 2019-12-12
PlS Planned sale
10,000 -2.7%
1.99
US$19,918 		10,000 -2.7% 1.99 US$19,918
2017-06-21 2017-06-20
PlS Planned sale
10,000 -3.5%
7.54
US$75,400 		10,000 -3.5% 7.54 US$75,400
2017-06-21 2017-06-20
PlS Planned sale
20,000 -6.5%
7.44
US$148,800 		20,000 -6.5% 7.44 US$148,800
2017-06-21 2017-06-20
PlS Planned sale
10,000 -3.1%
7.43
US$74,300 		10,000 -3.1% 7.43 US$74,300
2016-11-29 2016-11-25
S Sale
6,168 -2.0%
7.50
US$46,260 		6,168 -2.0% 7.50 US$46,260
2016-11-23 2016-11-23
S Sale
7,000 -2.2%
7.50
US$52,500 		7,000 -2.2% 7.50 US$52,500
2016-11-23 2016-11-22
S Sale
13,000 -3.9%
7.50
US$97,500 		13,000 -3.9% 7.50 US$97,500